{"id":"559309-8782","orgnr":"559309-8782","name":"Foresight Pharma AB","name_registered_on":"2021-03-30","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2021-03-30","business_description":"Bolaget ska bedriva medicinsk och medicinteknisk forskning, och därmed förenlig utveckling och innovationer inom livsvetenskaper med inriktning fa diagnostik och läkemedel. Driva hälso- och sjukvård, inkl hälsoinriktad prevention och liknande lösningar. Investera i och driva bolag inom företrädesvis livsvetenskaper och medicinteknik. Handel med och förvaltning av värdepapper, fastigheter och fastighetsförvaltning och därmed förenlig verksamhet.","industries":[{"code":"72101","name":"Bioteknisk forskning och utveckling"},{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"},{"code":"86212","name":"Annan allmän öppen hälso- och sjukvård, ej primärvård"}],"postal_address":{"street":"Karlavägen 12","care_of":"c/o Roland Andersson","postal_code":"22240","city":"LUND","country":"SE","municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"1","name":"1 - 499 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"never_registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-01-28","documents":{"annual_report":"/v1/documents/f1f52046-1587-44b8-9f5f-739bcd8a4149.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/05_5.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-03-06","documents":{"annual_report":"/v1/documents/0fc65cba-7563-465a-aac0-c003973480e4.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/10_4.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-02-12","documents":{"annual_report":"/v1/documents/ec6be023-a887-4c3d-b467-8829ca373b92.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/07_3.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"K2","signed_on":"2023-01-26","documents":{"annual_report":"/v1/documents/fc80ee4d-7530-437e-8b2f-bf8b6b756d9c.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/04_3.zip"}},{"from":"2021-03-30","to":"2021-12-31","framework":"K2","signed_on":"2022-02-11","documents":{"annual_report":"/v1/documents/6d90e8f5-296f-48e6-acee-bef3c3616da7.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/07_3.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":28500,"operating_profit":1479,"profit_after_financial_items":7134,"net_profit":6830,"total_assets":85710,"current_assets":51031,"equity":73162,"share_capital":25000,"unrestricted_equity":48162,"long_term_liabilities":0,"current_liabilities":12548,"tax_liabilities":304,"cash":32113,"equity_ratio":0.854,"net_sales_growth":-0.813,"source":{"annual_report":"2025-12-31","document":"/v1/documents/f1f52046-1587-44b8-9f5f-739bcd8a4149.xhtml"},"anchors":{"cash":{"text":"32 113","prefix":"Summa kassa och bank","suffix":"135 926"},"current_assets":{"text":"51 031"},"current_liabilities":{"text":"12 548"},"equity":{"text":"73 162"},"equity_ratio":{"text":"85,4"},"long_term_liabilities":{"text":"0","prefix":"långfristiga skulder"},"net_profit":{"text":"6 830","suffix":"103"},"net_sales":{"text":"28 500"},"operating_profit":{"text":"1 479"},"profit_after_financial_items":{"text":"7 134"},"share_capital":{"text":"25 000","prefix":"utgång"},"tax_liabilities":{"text":"304","prefix":"Skatteskulder"},"total_assets":{"text":"85 710","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"48 162","suffix":"Styrelsen"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-01-28","signatories":[{"name":"R*****","role":"Verkställande direktör"}]}}